Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Non-cash Items: 2023-2025

Historic Non-cash Items for Upstream Bio (UPB) over the last 1 years, with Sep 2025 value amounting to $3.4 million.

  • Upstream Bio's Non-cash Items rose 81.12% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 million, marking a year-over-year increase of 81.12%. This contributed to the annual value of $71.3 million for FY2024, which is 1433.26% up from last year.
  • Upstream Bio's Non-cash Items amounted to $3.4 million in Q3 2025, which was down 91.51% from $39.7 million recorded in Q2 2025.
  • Upstream Bio's Non-cash Items' 5-year high stood at $71.3 million during Q4 2024, with a 5-year trough of $1.9 million in Q3 2024.
  • In the last 3 years, Upstream Bio's Non-cash Items had a median value of $14.0 million in 2023 and averaged $24.0 million.
  • Data for Upstream Bio's Non-cash Items shows a peak YoY skyrocketed of 1,433.26% (in 2024) over the last 5 years.
  • Upstream Bio's Non-cash Items (Quarterly) stood at $4.6 million in 2023, then soared by 1,433.26% to $71.3 million in 2024, then spiked by 81.12% to $3.4 million in 2025.
  • Its Non-cash Items was $3.4 million in Q3 2025, compared to $39.7 million in Q2 2025 and $23.4 million in Q1 2025.